Genomatica Stock

genomatica.comIndustrial / MaterialsFounded: 2000Funding to Date: $251.4MM

Genomatica is the developer of manufacturing processes that enable their licensee partners to produce the world’s most widely-used chemicals a ‘better way,’ from alternative feedstocks, with better economics and greater sustainability than petroleum-based processes.

Register for Details

For more details on financing and valuation for Genomatica, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Genomatica.

Register Today

Team

Management Team

Priti Pharkya
Director of Strategy and Corporate Development
Christophe Schilling Ph.D
Co-Founder, Chief Executive Officer & Board Member
Kaspar Evertz
Executive Vice President, Commercial
Jeff Lievense Ph.D
Senior Advisor to the CEO, Bioengineering & Technology & Executive Vice President, Engineering
Steve Weiss
Head of Marketing

Board Members

Carlos Cabrera
Robert Pangborn Ph.D
Thomas Huot Ph.D
VantagePoint Capital Partners
Boris Ryabov Ph.D
Bright Capital
Christophe Schilling Ph.D
Michael Savage
William Caesar
Leighton Read MD
Alloy Ventures
Steve Jurvetson
Draper Fisher Jurvetson Management
William Baum

Other companies like Genomatica in the Materials sector

Sector
Last Round Est. Valuation
$5.27B
Sector
Last Round Est. Valuation
$1.62B
Sector
Last Round Est. Valuation
$553.65MM
Sector
Last Round Est. Valuation
$517.12MM
Sector
Last Round Est. Valuation
$1.86B
Sector
Last Round Est. Valuation
$1.58B
Sector
Last Round Est. Valuation
$685.14MM
Sector
Last Round Est. Valuation
$1.23B

News Highlights

Genomatica Acquires REG Life Sciences’ Assets
Adds capabilities to meet increasing demand for sustainable products
Genomatica Completes $90 Million Financing to Drive Technologies for More Sustainable Everyday Products
Accelerates expansion of product lines; strengthens partnership with Ginkgo Bioworks
Updated on: Sep 21, 2023